My watch list
my.bionity.com  
Login  

20 Current news about the topic rabies

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Team of researchers in Vienna has decoded the structure of the ribonucleoprotein (RNP) of rabies virus

02-Aug-2019

A research team of the Institute of Virology of the University of Veterinary Medicine Vienna has achieved a major breakthrough in exploring the rabies virus: for the first time, researchers were able to exactly depict the structure of the RNP of this virus that is highly dangerous to terrestrial ...

more

CEPI awards US$ 34M contract to CureVac

28-Feb-2019

The Coalition for Epidemic Preparedness Innovations (CEPI) and CureVac AG have announced a partnership agreement worth up to US$ 34 million for the ongoing development of The RNA Printer™ prototype—a transportable, down-scaled, automated messenger RNA (mRNA) printing facility. This platform will ...

more

CureVac enters clinical phase with mRNA vaccine

First data expected on intramuscular application of the newly developed vaccine

25-Oct-2018

CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced the initiation of its Phase I dose-escalation clinical trial with the novel mRNA-based rabies vaccine, CV7202. This is the first-in-human clinical trial of CureVac’s naturally ...

more

Stem cells help researchers peg rabies resistance

20-Mar-2015

Researchers at Texas A&M AgriLife Research have developed a new technology to determine sensitivity or resistance to rabies virus."We were able to create a novel platform such that we could look at how pathogens, such as bacteria or virus or even drugs or radiation, interact with specific human ...

more

image description
The raccoon spreads dangerous diseases as it invades Europe

30-Aug-2012

Furry, agile, intelligent and voracious: the raccoon is far from being a cuddly toy, which is what many people believe when they get one as a pet. It is more like an invader that escapes and is able to adapt and survive in new habitats. According to a study, its expansion across Spain and Europe ...

more

Crucell Reaches Agreement with Sanofi Pasteur on Programs in the Field of Paediatric and Respiratory Vaccines

09-Jul-2010

Crucell N.V. announced that Crucell and sanofi pasteur reached an agreement on a series of transactions to restructure their long standing partnership. Crucell will waive its right to terminate an existing license agreement between Crucell Switzerland and sanofi pasteur's subsidiary Shantha ...

more

Novartis to expand its human vaccines presence in China through proposed acquisition of a majority stake in Zhejiang Tianyuan

05-Nov-2009

Novartis has reached an agreement to acquire an 85% stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. as part of a strategic initiative to build a vaccines industry leader in this country and expand the Group's limited presence in this fast-growing market ...

more

Boehringer Ingelheim Animal Health closes deal to acquire a significant portion of the Fort Dodge Animal Health Business

28-Oct-2009

Boehringer Ingelheim together with its U.S. animal health business Boehringer Ingelheim Vetmedica, Inc., announced that it has closed its deal with Pfizer to acquire a significant portion of the Fort Dodge Animal Health business. The acquisition, which includes products in the U.S., Australia, ...

more

Crucell Rabies Monoclonal Antibody Combination: Positive Results Philippines Phase II Study Presented at RITA Conference

22-Oct-2009

Crucell N.V. announced that detailed results of the Phase II Philippines study of its rabies monoclonal antibody combination (CL 184) were presented at the XX Rabies in the Americas (RITA) Conference in Quebec, Canada. The presentation was given by Dr Beatriz P. Quiambao (MD), Chief Clinical ...

more

GlycoVaxyn AG Appoints Dr Stanley Plotkin to Supervisory Board

08-Oct-2009

GlycoVaxyn announced that the vaccinologist Dr Stanley A Plotkin has been elected to its Supervisory Board. Among his achievements, Dr Plotkin developed a vaccine against the rubella virus. This rubella vaccine continues to be in standard use throughout the world today. He is also co-developer ...

more

Page 1 From 2
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE